ABSTRACT
INTRODUCTION
Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathies affecting motor and sensory nerves of the peripheral nervous system (1).
The disease has been classified as demyelinating (CMT1), axonal (CMT2) and intermediate forms of CMT based on nerve conduction velocities. Mutations in more than 36 genes have been identified in different forms of CMT (http://www.molgen.ua.ac.be/CMTMutations/). Length-dependent peripheral neuropathy in CMT1 due to mutations in genes expressed in myelinating Schwann cells have led to an appreciation of the importance of Schwann cells in maintaining axonal transport and axonal homeostasis (2) . However, it is less clear how mutations in neuronal genes in CMT2 lead to peripheral neuropathy, especially since most diseasecausing genes are widely expressed and the deleterious effects are limited to motor and/or sensory neurons.
Mutations of NFL in an autosomal-dominant axonal form of CMT type 2E (CMT2E) were first described in 2000 (3) . Since then, 13 additional mutations in NFL have been identified, most are missense mutations in the assembly-sensitive head and central rod domains of the NFL subunit (4) (5) (6) (7) (8) (9) . Functional studies have shown that CMT2E mutations disrupt assembly of mutant NFL with itself, with wild-type NFL and with the mid-sized (NFM) and heavy (NFH) NF subunits, and lead to aggregation of mutant protein in SW13 Vim -cells, neuronal cell lines, cultured rat cortical neurons and DRG neurons (10) (11) (12) (13) (14) . Expression of CMT mutant NFL is also disruptive to translocation of NFs, mitochondria and components of anterograde and retrograde rapid axonal transport (10, 13) . The latter studies have led to the view that motor neuron degeneration may arise from impairment of axonal transport due to NFL protein aggregation. However, it is also possible that aggregation of NFL protein may have direct neurotoxic properties to which motor neurons are particularly susceptible. The latter interpretation is strengthened by the findings that abnormal protein aggregation is a common and widely recognized pathogenic mechanism leading to selective degeneration of neurons-at-risk in other neurodegenerative diseases (15) .
More recently, mutations in small heat-shock proteins (sHSPs) B1 (HSPB1, Hsp27) and B8 (HSPB8, Hsp22) have been identified in CMT2F (16) (17) (18) and CMT2L (16, 19, 20) .
As members of the sHSP family, HSPB1 and HSPB8 share a conserved α-crystallin domain of approximately 90 amino acid residues, flanked by variable amino-and carboxyl-terminal extensions (21) (22) (23) . sHSPs reside as dynamic oligomers of monomeric units that undergo partial disassembly as they interact with substrates and impart their chaperone activities. They interact widely in the crowded microenvironment of the cell, including with subunits of microfilaments, intermediate filaments (IF) and microtubules (22) . Their interactions with IFs are important for maintaining the integrity of IF networks (24) . However, interactions between IFs and associated sHSPs can be disrupted by disease-causing mutations in either IFs or sHSPs, leading to signature pathological aggregates of mutant IFs or sHSP in degenerative diseases of muscle (25) , lens (26) and glial cells (27, 28) .
Disruption of assembly and aggregation of NFL not only occur from mutations of NFL in CMT2E (4-9), but also from mutations of HSPB1 in CMT2F (18, 29) and of HSPB8 in CMT2L (19) . Also, disease-causing mutations enhance the interactions between HSPB1 and HSPB8, suggesting that they may be part of a common pathway (30) .
In this study, we analyze and compare the pathological effects from expression of CMT mutants of NFL and HSPB1 in primary cultured motor neurons. We show that CMT mutations of NFL and HSPB1 have similar disruptive effects on NF network, leading to aggregation of NFL protein with progressive degeneration and loss of viability of motor neurons. While co-expression of wild-type HSPB1 diminishes the toxic effects of CMT mutant NFL, expression of S135F mutant HSPB1 has a dominant effect on disruption of NF assembly and leads to progressive degeneration and loss of motor neurons.
Furthermore, we show that deletion of NFL markedly reduces degeneration and loss of motor neuron viability induced by S135F mutant HSPB1. The findings indicate that disruption of NF network with aggregation of NFL may represent a common upstream pathway in motor neuron disease.
RESULTS

Expression of CMT mutant NFL causes degeneration and loss of viability of primary cultured motor neurons.
Primary cultured motor neurons derived from E13 mouse spinal cord were analyzed for pathological changes and loss of viability following microinjection of human wild-type or CMT mutant NFL cDNAs. Co-expression of a GFP reporter transgene enables live motor neurons to be monitored for up to one week following cDNA microinjection (31).
On day 1 after cDNA microinjection, targeted motor neurons injected with wild-type or (Fig. 1M) . Expression of P8R mutant NFL causes an earlier and larger loss of injected motor neurons compared with Q333P mutant NFL (Fig. 1M) . By day 5, there is >60% loss of motor neurons expressing P8R or Q333P mutant NFL (Fig. 1M) .
To investigate the effects of levels of CMT mutant NFL expression on motor neuron viability, cultured motor neurons were microinjected with different amounts of P8R mutant NFL cDNAs. Motor neurons injected with 50ng/μl of P8R mutant NFL show early and progressive loss of fluorescent motor neurons in cultures, similar to the loss of motor neurons injected with 200ng/μl of P8R mutant NFL cDNA (Fig. 1N) . The findings indicate that low-level expression of CMT mutant NFL is able to impair motor neuron viability, similar to the viability of motor neurons expressing much higher levels of wildtype NFL (Fig. 1M ).
Expression of P8R and Q333P CMT mutant NFL causes disruption of NF network
and aggregation of NFL in primary cultured motor neurons.
To investigate the effects of CMT mutant NFL on NF network, motor neurons were fixed and examined for NFL immunoreactivity following co-injection of wild-type or CMT mutant NFL with GFP cDNAs. When motor neurons are microinjected with wild-type NFL cDNA, NFL immunoreactivity is enhanced throughout perikarya and neuritic processes of targeted neurons (Fig. 2B ) and, like non-injected motor neurons, is present in filamentous arrays (Fig. 2B) Similarly, HSPB1 is also co-precipitated with wild-type and CMT mutant NFL by NFL antibodies (Fig. 3L) . Together, the data demonstrates that HSPB1 interacts with both wild-type and CMT mutant NFL in vivo and suggests that HSPB1 could play a role in modulating the aggregative properties of CMT mutant NFL.
HSPB1 reduces aggregation and induces reversal of CMT mutant NFL aggregates.
To study the role of HSPB1 in modulating the aggregative properties of CMT mutant 
HSPB1 reduces P8R CMT mutant NFL-induced loss of motor neuron in cultures.
To investigate the role of HSPB1 in modulating the neurotoxicity of CMT mutant NFL, we next assessed the effects of HSPB1 expression on viability of motor neurons expressing CMT mutant NFL. When motor neurons were microinjected with GFPtagged P8R mutant NFL cDNA, expression of P8R mutant NFL causes progressive decline in the number of fluorescent motor neurons ( Fig. 5 ), similar to the loss of motor neurons injected with untagged P8R mutant NFL cDNA ( Fig. 1) . However, co-injection of HSPB1 cDNA markedly reduces the loss of motor neurons expressing GFP-P8R mutant NFL (Fig. 5 ). The findings demonstrate that HSPB1 reduces the neurotoxicity of CMT mutant NFL in motor neurons and suggest that HSPB1 is an important factor regulating the aggregation and neurotoxicity of CMT mutant NFL.
S135F mutant HSPB1 has dominant effects on disruption of assembly and aggregation of NFL protein.
The ability of CMT mutant HSPB1 to disrupt assembly and promote aggregation of NFL in transfected cells (18) raises the possibility that altered assembly and aggregation of NFL play a role in the pathogenesis of CMT2F. To investigate this possibility, we first analyzed the deleterious effects of disease-causing S135F mutant HSPB1 on NFL assembly. We found that, when transfected alone into SW13Vim -cells, human wildtype NFL assembles into filamentous network (Fig. 6A ) and undergoes minimal aggregation (Fig. 6B ), S135F mutant HSPB1 is diffusely distributed in the cytoplasm (Fig. 6C) 6J ) and NSC34 cells (Fig. 6K) . Together, the data demonstrate that S135F mutant HSPB1 has a dominant disruptive effect on NF assembly in non-neuronal and neuronal cells that is not overcome by wild-type HSPB1. Similar phenomena were observed with GFP-tagged human wild-type NFL (data not shown).
S135F mutant HSPB1 associates with wild-type and CMT mutant NFL.
To investigate the biochemical basis underlying the dominant effects of S135F mutant HSPB1 on disruption of NF assembly, we examined the interactions of S135F mutant HSPB1 with wild-type and CMT mutant NFL by co-immunoprecipitation assay. We found that both wild-type and CMT mutant (P8R and Q333P) NFL are co-precipitated with S135F mutant HSPB1 (Figs. 7A and B) . Co-immunoprecipitation assay further
shows that wild-type and S135F mutant HSPB1 associate with endogenous NFL (Fig. 7C ). The results demonstrate that wild-type and S135F mutant HSPB1 interact with NFL and suggest that disruption of NF assembly and aggregation of NFL is a pathway underlying the neurotoxicity of CMT mutant HSPB1.
Expression of CMT mutant HSPB1 causes degeneration and loss of viability of cultured motor neurons.
In order to address the toxicity of mutant HSPB1 on motor neurons, we first established (Fig. 8G) . However, motor neurons co-injected with 200 ng/μl of S135F mutant HSPB1 cDNA and GFP reporter gene show early and rapid loss of motor neuron during the same post-injection interval (Fig. 8G) . Co-injection of 50 ng/μl of S135F mutant HSPB1 cDNA with GFP transgene shows reduced rapidity and severity in loss of motor neurons (Fig. 8G ). The results demonstrate that S135F mutant HSPB1 has severe neurotoxic effects on cultured motor neurons and the effects are dosedependent.
Expression of S135F mutant HSPB1 causes disruption of NF network and aggregation of NFL in motor neurons.
To investigate the effects of CMT mutant HSPB1 on NF network in motor neurons, we examined NFL immunoreactivity in targeted motor neurons. When motor neurons are injected with wild-type HSPB1, HSPB1 immunoreactivity is widely distributed in the perikarya and neurites (Fig. 9A) , and the endogenous NFL appears as filamentous arrays (Figs. 9B-C NFL-null motor neurons are resistant to S135F mutant HSPB1-induced neurotoxicity.
We next set out to probe the role of NFL in CMT mutant HSPB1 toxicity using NFL-null motor neurons prepared from NFL-knockout mice (32) . Deletion of NFL does not alter the growth and development of motor neurons in cultures ( Supplementary Fig. 2 ). When NFL-null motor neurons were microinjected with 200 ng/μl of S135F mutant HSPB1 cDNA and 100 ng/μl of GFP reporter transgene, GFP fluorescence outlines the neurites and perikarya of targeted neurons (Fig. 10A) . GFP fluorescence remains unaltered in the same neuron on day 3 ( Fig. 10B ) and day 5 ( Fig. 10C ) after microinjection.
Examination of the same neuron by phase contrast microscopy reveals preservation of perikarya, nucleus and nucleolus structures (Fig. 10D, insert) , confirming the lack of degenerative changes in targeted NFL-null motor neurons expressing S135F mutant Next we compared the toxicity of S135F mutant HSPB1 in NFL (+/+) and NFL-null motor neurons. Whereas microinjection of 200 ng/μl of S135F mutant HSPB1 cDNA causes early and severe loss of NFL (+/+) motor neurons in cultures (Fig. 10E) , NFLnull motor neurons microinjecting with the same concentration of S135F mutant HSPB1
show minimal loss of viability (Fig. 10E ). The data demonstrate that deletion of NFL markedly reduces the toxicity of S135F mutant HSPB1 in motor neurons. Together, these studies indicate that NFL is instrumental in the neurotoxicity of CMT mutant HSPB1 and that disruption of NF network and aggregation of NFL is an important upstream pathway leading to motor neuron degeneration.
DISCUSSION
Modeling of disease in primary cultures of motor neurons has enabled a direct examination of the neurotoxic effects of disease-causing mutations in neurons-at-risk.
In this study, we show that expression of CMT mutant NFL or CMT mutant HSPB1 has neurotoxic effects on cultured motor neurons and that CMT mutations in NFL and in HSPB1 cause the same pattern of neurodegenerative changes in motor neurons. Compelling evidence that alterations in NF assembly with aggregation of NFL protein can lead to motor neuron degeneration is provided by the disruptive effects on the endogenous NF network in motor neurons from expression of S135F mutant HSPB1.
Interestingly, the ability of CMT mutant HSPB1 to disrupt NF assembly and cause aggregation of NFL protein cannot be overcome by co-expression of wild-type HSPB1, indicating a toxic dominant effect of S135F mutant HSPB1 on the NF network.
Biochemical studies show that S135F mutation does not impair the ability of HSPB1 to interact with NFL proteins. Therefore, it is possible that disruption of NFL assembly by S135F mutation in HSPB1 may be due to increased binding affinity, as suggested by disease-causing mutations in other sHSP (25) . Moreover, the dominant toxic effects of In summary, our hypothesis that disruption of NF network and aggregation of NFL protein is a triggering mechanism in motor neuron degeneration is supported by direct modeling of CMT mutant NFL and HSPB1-linked disease in motor neurons. As a triggering event of motor neuron dysfunction and degeneration, the changes could begin to explain the specific vulnerability of motor neurons in mice expressing NF transgenes, in transgenic models of disease as well as in sporadic and familial forms of motor neuron disease. As an upstream mechanism, disruption of assembly and aggregation of NFL protein could provoke the widespread degenerative and/or reactive changes in many diverse pathways of motor neurons and surrounding cells that have been well documented in motor neuron disease (58) . More importantly, the identification of a prospective upstream triggering mechanism could provide novel targets and/or strategies for effective treatment and palliation of motor neuron disease.
MATERIALS AND METHODS
DNA constructs and reagents
Full-length human NFL cDNA was purchased from GeneCopoeia (Maryland, USA) and was expressed either as untagged (pReceiver-M02/hNFL) or C-terminal GFP-tagged (pReceiver-M03/hNFL-GFP) NFL. Full-length HSPB1 cDNA was amplified by PCR and expressed as HA-tagged protein in pReceiver-M06 mammalian vector. Mutagenesis was performed using the QuikChange TM Site-directed Mutagenesis Kit (Stratagene). All constructs were verified by DNA sequencing. Primary antibodies used in this study were purchased from Roche Applied Science (anti-HA), Santa Cruz Biotechnology Inc.
(anti-GFP, anti-NFL, anti-NFM, anti-NFH and anti-HSPB1) and Upstate (anti-HSPB1).
Secondary antibodies were purchased from Molecular Probes.
Primary cultures of motor neurons and cDNA microinjection
Primary cultured motor neurons were prepared from NFL (+/+) or NFL (-/-) embryonic spinal cords as described (31) . NFL (-/-) mice (32) were gifts from Dr. Jean-Pierre Julien (Canada). Briefly, spinal cords were dissected from day 13 (E13) mouse embryos, dissociated with trypsin, and plated on poly-L-lysine (Sigma) precoated-12-mm glass coverslips (Fisher) at a density of 2X10 5 cells/well in 24-well culture plates.
Cells were grown in modified N3 medium and treated with 1.4 µg/ml cytosine arabinoside (Sigma) after 4 to 6 days culture to minimize growth of non-neuronal cells.
Cultures were subjected to cDNA microinjection after 6 weeks culture.
cDNA microinjection was conducted using a Zeiss Axiovert-10 microscope, Eppendorf 
Assessment of motor neuron viability
After cDNA microinjection, the numbers of motor neurons containing GFP fluorescence on each coverslip were counted under fluorescence microscopy during a 5-day interval.
The survival of injected motor neurons was confirmed by phase contrast microscopy.
Data was presented as percentage of survival motor neurons by normalizing the numbers of motor neurons from different time points to the numbers present on day 1.
Each experiment was performed in triplicate and conducted on a minimum of 60 injected motor neurons.
Cell culture and transfection
SW13Vim
-cells and neuronal cell lines (NSC34 cells and Neuro2a cells) were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (FBS). Cells were transfected using FuGene 6 Transfection Reagent (Roche Applied Science) following the manufacture's instructions.
Co-fractionation assay, co-immunoprecipitation assay and Western blot
At 48 h after transfection, SW13Vim -cells were lysed in cold lysis buffer (50 mM
Tris.HCl, pH 8.0, 300 mM NaCl, 1.5 mM MgCl 2 , 1% Triton X-100, 1mM PMSF and mammalian protease inhibitor cocktail (Sigma)) and centrifuged at 10,000 x g for 15 min
at 4°C to obtain Triton-soluble supernatants and Triton-insoluble pellets. Tritoninsoluble pellets were washed with lysis buffer three times and then boiled in Laemmli sample buffer. Similar amounts of supernatant and pellet fractions were analyzed by Western blots. For co-immunoprecipitation assay, Triton-soluble supernatants were incubated with antibodies at 4°C overnight. After four washes with lysis buffer, immunoprecipitates were boiled in SDS loading buffer, separated by 4~12% SDS-PAGE (Invitrogen) and subjected to Western blot analyses.
Fluorescence microscopy
Motor neurons were visualized by phase and fluorescence microscopy using a Nikon 
